CN106075575A - A kind of composite for knee osteoarthritis repair of cartilage and preparation method thereof - Google Patents
A kind of composite for knee osteoarthritis repair of cartilage and preparation method thereof Download PDFInfo
- Publication number
- CN106075575A CN106075575A CN201610490909.9A CN201610490909A CN106075575A CN 106075575 A CN106075575 A CN 106075575A CN 201610490909 A CN201610490909 A CN 201610490909A CN 106075575 A CN106075575 A CN 106075575A
- Authority
- CN
- China
- Prior art keywords
- cartilage
- collagen
- solution
- repair
- knee osteoarthritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 40
- 208000003947 Knee Osteoarthritis Diseases 0.000 title claims abstract description 34
- 210000000845 cartilage Anatomy 0.000 title claims abstract description 34
- 201000008482 osteoarthritis Diseases 0.000 title claims abstract description 33
- 230000008439 repair process Effects 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 108010035532 Collagen Proteins 0.000 claims abstract description 32
- 102000008186 Collagen Human genes 0.000 claims abstract description 32
- 108010022355 Fibroins Proteins 0.000 claims abstract description 32
- 229920001436 collagen Polymers 0.000 claims abstract description 32
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 30
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 30
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 30
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 34
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical class CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 10
- 238000004132 cross linking Methods 0.000 claims description 9
- 239000003431 cross linking reagent Substances 0.000 claims description 8
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 6
- 239000001110 calcium chloride Substances 0.000 claims description 6
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 4
- 210000002435 tendon Anatomy 0.000 claims description 4
- 235000015278 beef Nutrition 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 241000251468 Actinopterygii Species 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000012460 protein solution Substances 0.000 claims 3
- 241000255791 Bombyx Species 0.000 claims 2
- 238000001914 filtration Methods 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 206010013786 Dry skin Diseases 0.000 claims 1
- 241000282894 Sus scrofa domesticus Species 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000000084 colloidal system Substances 0.000 claims 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 1
- 229910000029 sodium carbonate Inorganic materials 0.000 claims 1
- 125000002730 succinyl group Chemical group C(CCC(=O)*)(=O)* 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 5
- 230000005847 immunogenicity Effects 0.000 abstract description 4
- 230000008929 regeneration Effects 0.000 abstract description 4
- 238000011069 regeneration method Methods 0.000 abstract description 4
- 230000015556 catabolic process Effects 0.000 abstract description 3
- 230000024245 cell differentiation Effects 0.000 abstract description 3
- 230000004663 cell proliferation Effects 0.000 abstract description 3
- 238000006731 degradation reaction Methods 0.000 abstract description 3
- 239000012567 medical material Substances 0.000 abstract description 3
- 230000035790 physiological processes and functions Effects 0.000 abstract description 3
- 230000007547 defect Effects 0.000 abstract description 2
- 230000001050 lubricating effect Effects 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 238000000502 dialysis Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 238000011883 total knee arthroplasty Methods 0.000 description 4
- 210000001188 articular cartilage Anatomy 0.000 description 3
- 210000001179 synovial fluid Anatomy 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 241000255789 Bombyx mori Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- -1 and at the same time Polymers 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000005553 drilling Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 238000012148 non-surgical treatment Methods 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000013201 Stress fracture Diseases 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 208000037873 arthrodesis Diseases 0.000 description 1
- 238000011882 arthroplasty Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- RAABOESOVLLHRU-UHFFFAOYSA-N diazene Chemical compound N=N RAABOESOVLLHRU-UHFFFAOYSA-N 0.000 description 1
- 229910000071 diazene Inorganic materials 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001476 gene delivery Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005297 material degradation process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- A61L2300/604—Biodegradation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明公开一种用于膝骨性关节炎软骨修复的复合材料,由丝素蛋白、胶原和透明质酸制成,其中丝素蛋白:胶原:透明质酸的质量比为30:60~70:2.5~10。本发明还公开其制备方法,该方法过程简单,原料易得廉价。所得复合材料可改善胶原机械性能不足、降解过快的缺点,同时兼具透明质酸的润滑作用,促进细胞的增殖、分化和改善关节的重要生理过程。本发明获得的复合材料具有良好的生物相容性、可降解性和无免疫原性的特点,能有效促进软骨的重建和再生,是一种较好的适用于中、早期膝骨性关节炎软骨缺损修复的医用材料。
The invention discloses a composite material for knee osteoarthritis cartilage repair, which is made of silk fibroin, collagen and hyaluronic acid, wherein the mass ratio of silk fibroin: collagen: hyaluronic acid is 30:60~70 : 2.5~10. The invention also discloses a preparation method thereof, which has simple process and easy-to-obtain and cheap raw materials. The obtained composite material can improve the disadvantages of insufficient mechanical properties and rapid degradation of collagen, and at the same time has the lubricating effect of hyaluronic acid, promotes cell proliferation and differentiation, and improves important physiological processes of joints. The composite material obtained by the present invention has the characteristics of good biocompatibility, degradability and non-immunogenicity, can effectively promote the reconstruction and regeneration of cartilage, and is a kind of better suitable for middle and early knee osteoarthritis Medical material for cartilage defect repair.
Description
技术领域technical field
本发明属于生物医用领域,具体涉及一种用于膝骨性关节炎软骨修复的复合材料及其制备方法。The invention belongs to the field of biomedicine, and in particular relates to a composite material for knee osteoarthritis cartilage repair and a preparation method thereof.
背景技术Background technique
膝骨性关节炎(KOA)是一种由于患者膝关节软骨出现变形、骨质增生以及坏死等炎症性病变为特征的骨关节疾病,以关节软骨退行性改变甚至消失为主要病理特征,目前临床对KOA的治疗主要分为手术治疗和非手术治疗两种。手术治疗主要方法有:自体或同种异体骨软骨移植、组织移植、关节清理术、钻孔术以及膝关节周围截骨术、膝关节融合术、人工全膝关节置换术(TKA)等。TKA虽然治疗KOA有效,但主要用于晚期患者,同时也存在花费高、手术创伤大、假体磨损等问题。对于年轻KOA 早期关节软骨磨损较轻的患者,TKA并不是最佳选择。在其它手术方法中,与钻孔术、关节成型术、微骨折术等相比,临床证实自体镶嵌式骨软骨移植有长期明显临床疗效,但其缺点是以牺牲其他软骨为代价。因此,发展一种可有效修复KOA软骨缺损的材料势在必行。Knee osteoarthritis (KOA) is a bone and joint disease characterized by inflammatory lesions such as deformation, hyperosteogeny, and necrosis of the knee articular cartilage in patients. The main pathological feature is the degeneration or even disappearance of articular cartilage. The treatment of KOA is mainly divided into surgical treatment and non-surgical treatment. The main methods of surgical treatment are: autologous or allogeneic osteochondral transplantation, tissue transplantation, joint debridement, drilling, osteotomy around the knee joint, knee arthrodesis, total knee arthroplasty (TKA), etc. Although TKA is effective in the treatment of KOA, it is mainly used for advanced patients, and there are also problems such as high cost, large surgical trauma, and wear and tear of the prosthesis. For young patients with mild articular cartilage wear in the early stage of KOA, TKA is not the best choice. Among other surgical methods, compared with drilling, arthroplasty, and microfracture, it has been clinically proven that autologous mosaic osteochondral transplantation has significant long-term clinical efficacy, but its disadvantage is at the expense of other cartilage. Therefore, it is imperative to develop a material that can effectively repair KOA cartilage defects.
在用于软骨组织工程的天然材料中,丝素蛋白具有良好的生物相容性,可维持软骨细胞正常生长状态和性能,用于软骨及骨重建和再生。作为动物体内含量最丰富、分布最广泛的蛋白质,胶原具有独特的三螺旋结构、低抗原性、无毒性、良好的生物相容性和生物可降解性等特点,已被广泛应用于组织工程支架材料、药物控缓释系统、基因传递载体、美容外科等生物医用领域。Among the natural materials used in cartilage tissue engineering, silk fibroin has good biocompatibility, can maintain the normal growth state and performance of chondrocytes, and is used for cartilage and bone reconstruction and regeneration. As the most abundant and widely distributed protein in animals, collagen has the characteristics of unique triple helix structure, low antigenicity, non-toxicity, good biocompatibility and biodegradability, and has been widely used in tissue engineering scaffolds Biomedical fields such as materials, drug controlled and sustained release systems, gene delivery carriers, cosmetic surgery, etc.
透明质酸是皮肤和其它组织中广泛存在的天然生物分子,是构成人体细胞间质、关节滑液等结缔组织的主要成分,它填充在细胞与胶原纤维空间之中且覆盖在某些表皮组织上,广泛分布于人体的软结缔组织中,在关节腔中几乎以纯态形式存在。它能促进细胞的增殖、分化,清除氧自由基,促进伤口愈合、调节渗透压、润滑、促进细胞修复及改善关节的重要作用。在临床KOA非手术治疗中,补充外源性透明质酸是常用方法之一,具有提高滑液中透明质酸含量、改善病理情况下滑液的生理功能、缓解关节疼痛、保护软骨和滑膜免受破坏等作用。Hyaluronic acid is a natural biomolecule widely present in skin and other tissues. It is the main component of connective tissues such as human intercellular matrix and joint synovial fluid. It fills the space between cells and collagen fibers and covers some epidermal tissues. On the human body, it is widely distributed in the soft connective tissue of the human body, and exists in almost pure form in the joint cavity. It can promote cell proliferation and differentiation, scavenge oxygen free radicals, promote wound healing, regulate osmotic pressure, lubricate, promote cell repair and improve joints. In clinical KOA non-surgical treatment, supplementing exogenous hyaluronic acid is one of the commonly used methods, which can increase the content of hyaluronic acid in synovial fluid, improve the physiological function of synovial fluid under pathological conditions, relieve joint pain, protect cartilage and synovial membrane damaged etc.
本发明结合天然胶原、丝素蛋白和透明质酸的优点,制备一种可用于膝骨性关节炎软骨修复的复合材料。它可作为内原性骨髓来源干细胞粘附、增殖和分化的支架,同时通过材料降解产生的透明质酸增强修复效果的同时,达到缓解和治疗KOA的目的。The invention combines the advantages of natural collagen, silk fibroin and hyaluronic acid to prepare a composite material that can be used for knee osteoarthritis cartilage repair. It can be used as a scaffold for the adhesion, proliferation and differentiation of endogenous bone marrow-derived stem cells, and at the same time, the hyaluronic acid produced by material degradation can enhance the repair effect and achieve the purpose of alleviating and treating KOA.
发明内容Contents of the invention
本发明的目的是提供一种用于膝骨性关节炎软骨修复的复合材料及其制备方法。所得复合材料,具有良好的生物相容性、可降解性和无免疫原性的特点,能有效促进软骨的重建和再生,是一种较好的适用于中、早期膝骨性关节炎软骨缺损修复的医用材料。The object of the present invention is to provide a composite material for knee osteoarthritis cartilage repair and a preparation method thereof. The obtained composite material has the characteristics of good biocompatibility, degradability and non-immunogenicity, and can effectively promote the reconstruction and regeneration of cartilage. Repairing medical materials.
为实现上述目的,本发明采用以下技术方案:To achieve the above object, the present invention adopts the following technical solutions:
一种用于膝骨性关节炎软骨修复的复合材料以丝素蛋白溶液、胶原、透明质酸为原料制得,其中丝素蛋白:胶原:透明质酸的质量比为30:60~70:2.5~10。A composite material for knee osteoarthritis cartilage repair is made from silk fibroin solution, collagen, and hyaluronic acid as raw materials, wherein the mass ratio of silk fibroin:collagen:hyaluronic acid is 30:60~70: 2.5~10.
所述胶原为源于鱼皮、猪皮、牛皮或牛腱。The collagen is derived from fish skin, pig skin, cow hide or beef tendon.
所述用于膝骨性关节炎软骨修复的复合材料的制备方法包括如下步骤:The preparation method of the composite material for knee osteoarthritis cartilage repair comprises the following steps:
(1)制备丝素蛋白溶液;(1) Prepare silk fibroin solution;
(2)分别将胶原、透明质酸溶于浓度为1 mol/L丙二酸中制备成一定浓度的胶原溶液和透明质酸溶液;所述胶原与丙二酸的质量比为0.4:100;所述透明质酸与丙二酸的质量比为0.5:100;(2) Dissolving collagen and hyaluronic acid in 1 mol/L malonic acid to prepare a certain concentration of collagen solution and hyaluronic acid solution; the mass ratio of collagen to malonic acid is 0.4:100; The mass ratio of described hyaluronic acid and malonic acid is 0.5:100;
(3)将步骤(1)所得丝素蛋白溶液与步骤(2)所得的胶原溶液和透明质酸溶液混合,搅拌均匀,冷冻干燥后添加交联剂进行交联10h;所述交联剂由1-乙基-3(3-二甲基氨丙基)碳化二亚胺(EDC)、N-羟基丁二酰(NHS)和90%的乙醇溶液制得,其中EDC/NHS的质量比为5:2。(3) Mix the silk fibroin solution obtained in step (1) with the collagen solution and hyaluronic acid solution obtained in step (2), stir evenly, freeze-dry and add a cross-linking agent for cross-linking for 10 hours; the cross-linking agent consists of 1-ethyl-3 (3-dimethylaminopropyl) carbodiimide (EDC), N-hydroxysuccinyl (NHS) and 90% ethanol solution, wherein the mass ratio of EDC/NHS is 5:2.
(4)交联后反复用蒸馏水或去离子水冲洗除去多余交联剂,二次冷冻干燥即得用于膝骨性关节炎软骨修复的复合材料。(4) After cross-linking, rinse with distilled water or deionized water repeatedly to remove excess cross-linking agent, and freeze-dry the second time to obtain a composite material for knee osteoarthritis cartilage repair.
其中丝素蛋白溶液的制备方法如下:Wherein the preparation method of silk fibroin solution is as follows:
1)将剪碎的蚕茧放入Na2CO3溶液中,在水浴中放置30min,去除蚕茧上胶质,反复操作3次后烘干,得到丝素;其中Na2CO3溶液的质量分数为0.5%,水浴温度为98±2℃。1) Put the shredded silk cocoons into Na 2 CO 3 solution, place them in a water bath for 30 minutes, remove the gum on the cocoons, repeat the operation 3 times, and then dry them to obtain silk fibroin; the mass fraction of the Na 2 CO 3 solution is 0.5%, the water bath temperature is 98±2℃.
2)称取步骤1)所述的丝素,在78℃下,在CaCl2/H2O/C2H5OH混合溶液中溶解,纱布过滤,得到粗滤液;其中CaCl2/H2O/C2H5OH混合溶液中CaCl2/H2O/C2H5OH的摩尔比1:8:2;丝素与CaCl2/H2O/C2H5OH混合溶液的质量比为1:25。2) Weigh the silk fibroin described in step 1), dissolve it in the mixed solution of CaCl 2 /H 2 O/C 2 H 5 OH at 78°C, and filter it through gauze to obtain the coarse filtrate; where CaCl 2 /H 2 O The molar ratio of CaCl 2 /H 2 O/C 2 H 5 OH in /C 2 H 5 OH mixed solution is 1:8:2; the mass ratio of silk fibroin to CaCl 2 /H 2 O/C 2 H 5 OH mixed solution for 1:25.
3)将步骤2)所得粗滤液倒入透析袋中透析3 d,除去氯化钙和乙醇;再过滤,得到丝素蛋白溶液;所用透析袋的截留分子量为8000-14000。3) Pour the crude filtrate obtained in step 2) into a dialysis bag for dialysis for 3 days to remove calcium chloride and ethanol; then filter to obtain a silk fibroin solution; the molecular weight cut-off of the dialysis bag used is 8000-14000.
本发明制备的用于膝骨性关节炎软骨修复的复合材料呈三维网状结构,具有良好的吸湿性,制备过程简单、价廉易得。所得材料可改善胶原机械性能不足、降解过快的缺点,同时透明质酸可发挥润滑作用,促进细胞的增殖,分化和改善关节的重要生理过程。该复合材料具有良好的生物相容性、可降解性和无免疫原性的特点,能有效促进软骨的重建和再生,是一种较好的适用于中、早期膝骨性关节炎软骨缺损修复的医用材料。The composite material for knee osteoarthritis cartilage repair prepared by the invention has a three-dimensional network structure, good hygroscopicity, simple preparation process, low price and easy availability. The obtained material can improve the shortcomings of insufficient mechanical properties and rapid degradation of collagen, and at the same time, hyaluronic acid can play a lubricating role, promote cell proliferation, differentiation and improve important physiological processes of joints. The composite material has the characteristics of good biocompatibility, degradability and non-immunogenicity, and can effectively promote the reconstruction and regeneration of cartilage. of medical materials.
附图说明Description of drawings
图1是用于膝骨性关节炎软骨修复的复合材料的红外光谱图,a:交联前,b:交联后。Figure 1 is the infrared spectrum of the composite material used for knee osteoarthritis cartilage repair, a: before cross-linking, b: after cross-linking.
图2是用于膝骨性关节炎软骨修复的复合材料的扫描电镜图,从A-E分别代表实施例中第一组至第五组所得复合材料。Fig. 2 is a scanning electron micrograph of the composite material used for knee osteoarthritis cartilage repair, and A-E respectively represent the composite materials obtained in the first group to the fifth group in the embodiment.
具体实施方式detailed description
用于膝骨性关节炎软骨修复的复合材料的制备Preparation of Composite Materials for Cartilage Repair in Osteoarthritis of the Knee
实施例1Example 1
1) 将剪碎的蚕茧放入0.5% Na2CO3溶液,98±2℃水浴中放置30 min,去除蚕茧上胶质,反复操作3次。放入60℃烘箱烘干后,得到丝素丝。称取上述脱胶后丝素丝,在78℃三元溶液CaCl2/H2O/C2H5OH溶液(摩尔比1:8:2)中溶解,浴比1:25,纱布过滤。将溶液倒入截留分子量为8000-14000的透析袋中透析3 d,除去氯化钙和乙醇;过滤,得到丝素蛋白溶液。1) Put the shredded silkworm cocoons into 0.5% Na 2 CO 3 solution, place them in a water bath at 98±2°C for 30 minutes, remove the gum on the silkworm cocoons, and repeat the operation 3 times. After drying in an oven at 60°C, silk fibroin is obtained. Weigh the above degummed silk fibroin, dissolve it in 78°C ternary solution CaCl 2 /H 2 O/C 2 H 5 OH solution (molar ratio 1:8:2), bath ratio 1:25, and filter through gauze. Pour the solution into a dialysis bag with a molecular weight cut-off of 8000-14000 and dialyze for 3 days to remove calcium chloride and ethanol; filter to obtain a silk fibroin solution.
2)称取1.3 g牛腱胶原溶于323.7 g浓度为1 mol/L丙二酸溶液中,放置在搅拌器上搅拌溶解,制备质量分数为0.4%的胶原溶液。2) Weigh 1.3 g of bovine tendon collagen and dissolve it in 323.7 g of 1 mol/L malonic acid solution, place it on a stirrer and stir to dissolve, and prepare a collagen solution with a mass fraction of 0.4%.
3)称取0.089 g透明质酸溶于19.9 g浓度为1 mol/L丙二酸溶液中,放置在搅拌器上搅拌溶解,制备质量分数为0.5%的胶原溶液。3) Weigh 0.089 g of hyaluronic acid and dissolve it in 19.9 g of malonic acid solution with a concentration of 1 mol/L, place it on a stirrer and stir to dissolve, and prepare a collagen solution with a mass fraction of 0.5%.
4)将丝素蛋白溶液与牛腱胶原溶液混合,放在磁力搅拌器上搅拌均匀,再缓慢加入透明质酸溶液,制成混合均匀的丝素蛋白/胶原/透明质酸溶液,其丝素蛋白(SF)/胶原(Col)/透明质酸(HA)的质量比为30:67.5:2.5。冷冻干燥;利用交联剂交联一次冻干的复合材料,反复用去离子水冲洗除去多余交联剂,其交联剂由1-乙基-3(3-二甲基氨丙基)碳化二亚胺、N-羟基丁二酰和90%乙醇溶液制得,其中EDC/NHS的质量比为5:2。然后二次冷冻干燥即得用于膝骨性关节炎软骨修复的复合材料,记为第一组,其交联前后的复合材料的红外图如图1。由图1可知:交联后复合材料在1234 cm-1和1450 cm-1处峰的吸收率比值接近于1,表明材料中胶原蛋白仍保持完整三级结构,生物学活性保存良好;与交联前(图1a)比较,交联后复合材料1630 cm-1(酰胺Ⅰ带C=O伸缩振动峰)和1234 cm-1(酰胺Ⅲ带)处吸收峰的位置和强度发生了改变,材料发生了有效交联,有利于复合材料的抗降解性能和机械性能的提高。4) Mix the silk fibroin solution with the beef tendon collagen solution, put it on a magnetic stirrer and stir evenly, then slowly add the hyaluronic acid solution to make a uniformly mixed silk fibroin/collagen/hyaluronic acid solution, the silk fibroin The mass ratio of protein (SF)/collagen (Col)/hyaluronic acid (HA) is 30:67.5:2.5. Freeze-drying; use a cross-linking agent to cross-link the freeze-dried composite material once, and repeatedly rinse with deionized water to remove the excess cross-linking agent. The cross-linking agent is carbonized by 1-ethyl-3 (3-dimethylaminopropyl) Diimine, N-hydroxysuccinyl and 90% ethanol solution, in which the mass ratio of EDC/NHS is 5:2. Then the composite material used for knee osteoarthritis cartilage repair was obtained by secondary freeze-drying, which was recorded as the first group. The infrared images of the composite material before and after crosslinking are shown in Figure 1. It can be seen from Figure 1 that after cross-linking, the ratio of the absorption rate of the peaks at 1234 cm -1 and 1450 cm -1 of the composite material is close to 1, indicating that the collagen in the material still maintains a complete tertiary structure, and the biological activity is well preserved; Compared with before linking (Fig. 1a), the positions and intensities of the absorption peaks at 1630 cm -1 (the C=O stretching vibration peak of the amide I band) and 1234 cm -1 (the amide III band) of the composite material changed after cross linking. Effective crosslinking occurs, which is beneficial to the improvement of the degradation resistance and mechanical properties of the composite material.
实施例2Example 2
改变步骤4)中丝素蛋白/胶原/透明质酸的质量比为30:65:5,其他步骤与实施例1相同,制备复合材料C。The mass ratio of silk fibroin/collagen/hyaluronic acid in step 4) was changed to 30:65:5, and other steps were the same as in Example 1 to prepare composite material C.
实施例3Example 3
改变步骤4)中丝素蛋白/胶原/透明质酸的质量比为30:62.5:7.5,其他步骤与实施例1相同,制备复合材料D。The mass ratio of silk fibroin/collagen/hyaluronic acid in step 4) was changed to 30:62.5:7.5, and other steps were the same as in Example 1 to prepare composite material D.
实施例4Example 4
改变步骤4)中丝素蛋白/胶原/透明质酸的质量比为30:60:10,其他步骤与实施例1相同,制备复合材料E。Composite material E was prepared by changing the mass ratio of silk fibroin/collagen/hyaluronic acid in step 4) to 30:60:10, and other steps were the same as in Example 1.
对比例:Comparative example:
改变步骤4)中丝素蛋白/胶原/透明质酸的质量比为30:70:0,其他步骤与实施例1相同,制备复合材料A。The mass ratio of silk fibroin/collagen/hyaluronic acid in step 4) was changed to 30:70:0, and other steps were the same as in Example 1 to prepare composite material A.
上述所得用于膝骨性关节炎软骨修复的复合材料的吸水率测试:The water absorption test of the above-mentioned composite material used for knee osteoarthritis cartilage repair:
分别称取0.01 g用于膝骨性关节炎软骨修复的复合材料(为W1),放于培养皿中每孔加入1800 mLPBS缓冲溶液,于37℃下放置24h,分别称其重量(为W2),吸水率(%)=(W2-W1)/W1×100%,每个实验平行做3次,取其平均值,结果如下:Weigh 0.01 g of the composite material (W 1 ) used for knee osteoarthritis cartilage repair, put it in a petri dish, add 1800 mL of PBS buffer solution to each well, place it at 37°C for 24 hours, and weigh its weight (W 1 ) respectively. 2 ), water absorption (%)=(W 2 -W 1 )/W 1 ×100%, each experiment was done 3 times in parallel, and the average value was taken, the results are as follows:
表1. 上述实施例所得复合材料的吸水率。Table 1. The water absorption of the composite material obtained in the above examples.
从上表可知,上述实施例和对比例所得用于膝骨性关节炎软骨修复的复合材料随透明质酸含量的升高,吸水率降低,但整体差别不大。It can be seen from the above table that the water absorption rate of the composite materials used for knee osteoarthritis cartilage repair obtained in the above examples and comparative examples decreases with the increase of hyaluronic acid content, but the overall difference is not significant.
上述实施例所得用于膝骨性关节炎软骨修复的复合材料呈三维网状结构(如图2所示),具有良好的吸湿性,生物相容性、可降解性和无免疫原性的特点。The composite material obtained in the above examples for knee osteoarthritis cartilage repair has a three-dimensional network structure (as shown in Figure 2), and has the characteristics of good hygroscopicity, biocompatibility, degradability and non-immunogenicity .
以上所述仅为本发明的较佳实施例,凡依本发明申请专利范围所做的均等变化与修饰,皆应属本发明的涵盖范围。The above descriptions are only preferred embodiments of the present invention, and all equivalent changes and modifications made according to the scope of the patent application of the present invention shall fall within the scope of the present invention.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610490909.9A CN106075575A (en) | 2016-06-28 | 2016-06-28 | A kind of composite for knee osteoarthritis repair of cartilage and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610490909.9A CN106075575A (en) | 2016-06-28 | 2016-06-28 | A kind of composite for knee osteoarthritis repair of cartilage and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106075575A true CN106075575A (en) | 2016-11-09 |
Family
ID=57214428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610490909.9A Pending CN106075575A (en) | 2016-06-28 | 2016-06-28 | A kind of composite for knee osteoarthritis repair of cartilage and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106075575A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108310461A (en) * | 2018-02-09 | 2018-07-24 | 武汉纺织大学 | Porous fibroin spinal cord rack with targeted release function and preparation method thereof prepares mold and application |
| CN111701073A (en) * | 2020-06-01 | 2020-09-25 | 天津大学 | A kind of joint injection preparation based on collagen-mimetic peptide modified hyaluronic acid and its preparation method and application |
| CN111701072A (en) * | 2020-06-01 | 2020-09-25 | 天津大学 | Joint injection preparation based on collagen-binding polypeptide modified hyaluronic acid and preparation method and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080131509A1 (en) * | 2006-12-04 | 2008-06-05 | Syed Hossainy | Methods and Compositions for Treating Tissue Using Silk Proteins |
| CN102380128A (en) * | 2011-10-31 | 2012-03-21 | 昆明理工大学 | Hydroxyapatite, sodium hyaluronate and konjac glucomannan composite material and preparation method thereof |
| CN103007336A (en) * | 2013-01-14 | 2013-04-03 | 福建省博特生物科技有限公司 | Fish skin collagen based composite sponge and preparation method thereof |
| CN101862475B (en) * | 2009-10-10 | 2013-08-07 | 广州市红十字会医院 | II type collagen hyaloplasm acid compound sponge bracket and use thereof |
-
2016
- 2016-06-28 CN CN201610490909.9A patent/CN106075575A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080131509A1 (en) * | 2006-12-04 | 2008-06-05 | Syed Hossainy | Methods and Compositions for Treating Tissue Using Silk Proteins |
| CN101862475B (en) * | 2009-10-10 | 2013-08-07 | 广州市红十字会医院 | II type collagen hyaloplasm acid compound sponge bracket and use thereof |
| CN102380128A (en) * | 2011-10-31 | 2012-03-21 | 昆明理工大学 | Hydroxyapatite, sodium hyaluronate and konjac glucomannan composite material and preparation method thereof |
| CN103007336A (en) * | 2013-01-14 | 2013-04-03 | 福建省博特生物科技有限公司 | Fish skin collagen based composite sponge and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| JIANHUA WANG等: ""Collagen/silk fibroin composite scaffold incorporated with PLGA microsphere for cartilage repair"", 《MATERIALS SCIENCE AND ENGINEERING C》 * |
| 何小维等: "《医药用碳水化合物 第1版》", 31 January 2016, 中国轻工业出版社 * |
| 吴炜等: ""胶原-透明质酸支架的制备及其与软骨细胞复合培养的实验研究"", 《中国修复重建外科杂志》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108310461A (en) * | 2018-02-09 | 2018-07-24 | 武汉纺织大学 | Porous fibroin spinal cord rack with targeted release function and preparation method thereof prepares mold and application |
| CN111701073A (en) * | 2020-06-01 | 2020-09-25 | 天津大学 | A kind of joint injection preparation based on collagen-mimetic peptide modified hyaluronic acid and its preparation method and application |
| CN111701072A (en) * | 2020-06-01 | 2020-09-25 | 天津大学 | Joint injection preparation based on collagen-binding polypeptide modified hyaluronic acid and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| El Blidi et al. | Extraction methods, characterization and biomedical applications of collagen: A review | |
| CN107073170B (en) | Biomaterial scaffolds for regenerating oral mucosa | |
| CN114949359B (en) | Acellular matrix particle filler and preparation method thereof | |
| RU2529803C2 (en) | Biological material applicable for therapy of osteoarthrosis, ligamentous injury and for treating joint pathologies | |
| de Souza et al. | Fish collagen for skin wound healing: A systematic review in experimental animal studies | |
| Abedi et al. | Collagen-based medical devices for regenerative medicine and tissue engineering | |
| CN104984407A (en) | Tissue engineering artificial skin and preparation method thereof | |
| CN106039416A (en) | Chitosan-sericin composite biological scaffold as well as preparation method and application thereof | |
| CN116285386B (en) | Cartilage tissue repair hydrogel and preparation method thereof | |
| CN113663137A (en) | Composite biological patch and preparation method and application thereof | |
| CN115894709A (en) | Recombinant human elastin with skin injury repair effect and application | |
| JP2019529015A (en) | Dermal layer for transplantation with increased survival rate and method for producing the same | |
| KR20180028229A (en) | The Method of High-yield and High-purity Manufacturing of Allo-collagen Composition Extracted From Human origin | |
| CN106075575A (en) | A kind of composite for knee osteoarthritis repair of cartilage and preparation method thereof | |
| CN103386145B (en) | Wound healing dressing containing carrageenan, and preparation method and application of wound healing dressing | |
| CN114573839B (en) | Preparation method of human hair keratin/chitosan hydrogel loaded with curcumin | |
| CN108273132A (en) | A kind of fibroin albumen/keratin composite porous material and preparation method thereof | |
| RU2353397C2 (en) | Bioabsorbable collagen matrix, method of production and application | |
| CN106620854A (en) | Elastin-like silk fiber porous composite material and application thereof | |
| CN103705976A (en) | Composite bone repair material and preparation method thereof | |
| CN108778353A (en) | Artificial composite membrane, preparation method and applications | |
| CN116920172A (en) | Collagen fiber-biological ceramic composite artificial bone and preparation method thereof | |
| CN115137883A (en) | Bionic composite mineralized scaffold and preparation method thereof | |
| WO2005039528A2 (en) | Composition for the treatment of arthrosis/arthritis, especially for treating joints | |
| RU2433828C1 (en) | Injection heterogenic biopolymer hydrogel for substitutional and regenerative surgery and method of its obtaining |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161109 |
|
| RJ01 | Rejection of invention patent application after publication |